-
公开(公告)号:US20180064746A1
公开(公告)日:2018-03-08
申请号:US15557652
申请日:2016-03-18
发明人: Carol W. Greider , Stella S. Lee
IPC分类号: A61K31/711 , C12N15/86 , A61K31/7105 , A61K31/713 , C12N15/113
CPC分类号: A61K31/502 , A61K31/4184 , A61K31/55 , A61K31/7105 , A61K31/711 , A61K31/713 , A61K45/06 , A61P7/00 , A61P7/06 , A61P11/00 , A61P17/00 , A61P35/00 , C12N9/1077 , C12N9/12 , C12N15/1137 , C12N15/86 , C12N2310/11 , C12N2310/14 , C12N2310/141 , C12N2310/3231 , C12N2310/531 , C12Q1/6851 , C12Q1/686 , C12Y204/0203 , C12Y207/11022 , A61K2300/00
摘要: The present invention provides an assay that identifies genes required for telomerase-dependent telomere elongation by measuring the de novo telomere addition at a single chromosome.
-
公开(公告)号:US20200078387A1
公开(公告)日:2020-03-12
申请号:US16469615
申请日:2017-12-15
发明人: Carol W. Greider , Steven Wang
IPC分类号: A61K31/7076 , G01N33/50 , A61K31/4439 , A61K31/4045 , A61K31/5377 , A61K31/551 , A61K31/655 , A61K31/4745 , A61K31/5025 , C12Q1/48 , A61K31/4725 , A61K31/519
摘要: The present invention relates generally to chromosome maintenance and cell viability, and more specifically, to the identification of kinases the inhibition of which blocks telomere elongation. In one aspect, the present invention provides methods for treating cancer. The methods generally comprise the administration of agents that interfere with the lengthening of telomeres in cancer. In a specific embodiment, a method of treating cancer in a subject by interfering with lengthening of telomeres in cancer cells comprises administering to the cells an effective amount of an inhibitor of casein kinase 1 (CK1), wherein the administration of the inhibitor leads to progressive telomere shortening in the cancer cell, thereby treating cancer in the subject. In another embodiment, the method can further comprise administering to the cells an effective amount of an inhibitor of bromodomain-containing protein 4 (BRD4) and/or an inhibitor of the MEK/ERK pathway.
-
公开(公告)号:US20240000821A1
公开(公告)日:2024-01-04
申请号:US18102197
申请日:2023-01-27
发明人: Carol W. Greider , Steven Wang
IPC分类号: A61K31/7076 , A61K31/4045 , A61K31/4439 , A61K31/4725 , A61K31/4745 , A61K31/5025 , A61K31/519 , A61K31/5377 , A61K31/551 , A61K31/655 , C12Q1/48 , G01N33/50
CPC分类号: A61K31/7076 , A61K31/4045 , A61K31/4439 , A61K31/4725 , A61K31/4745 , A61K31/5025 , A61K31/519 , A61K31/5377 , A61K31/551 , A61K31/655 , C12Q1/485 , G01N33/5011
摘要: The present invention relates generally to chromosome maintenance and cell viability, and more specifically, to the identification of kinases the inhibition of which blocks telomere elongation. In one aspect, the present invention provides methods for treating cancer. The methods generally comprise the administration of agents that interfere with the lengthening of telomeres in cancer. In a specific embodiment, a method of treating cancer in a subject by interfering with lengthening of telomeres in cancer cells comprises administering to the cells an effective amount of an inhibitor of casein kinase 1 (CK1), wherein the administration of the inhibitor leads to progressive telomere shortening in the cancer cell, thereby treating cancer in the subject. In another embodiment, the method can further comprise administering to the cells an effective amount of an inhibitor of bromodomain-containing protein 4 (BRD4) and/or an inhibitor of the MEK/ERK pathway.
-
公开(公告)号:US11156599B2
公开(公告)日:2021-10-26
申请号:US15557652
申请日:2016-03-18
发明人: Carol W. Greider , Stella S. Lee
IPC分类号: G01N33/50 , C12N15/86 , C12Q1/6851 , C12Q1/686 , C12N15/113 , C12N9/10
摘要: The present invention provides an assay that identifies genes required for telomerase-dependent telomere elongation by measuring the de novo telomere addition at a single chromosome.
-
公开(公告)号:US20180110777A1
公开(公告)日:2018-04-26
申请号:US15557393
申请日:2016-03-18
发明人: Carol W. Greider , Stella S. Lee
IPC分类号: A61K31/502 , C12Q1/6851 , C12Q1/686 , C12N9/10 , C12N9/12 , A61P7/00 , A61P7/06 , A61P11/00 , A61P35/00 , A61P17/00
CPC分类号: A61K31/502 , A61K31/4184 , A61K31/55 , A61K31/7105 , A61K31/711 , A61K31/713 , A61K45/06 , A61P7/00 , A61P7/06 , A61P11/00 , A61P17/00 , A61P35/00 , C12N9/1077 , C12N9/12 , C12N15/1137 , C12N15/86 , C12N2310/11 , C12N2310/14 , C12N2310/141 , C12N2310/3231 , C12N2310/531 , C12Q1/6851 , C12Q1/686 , C12Y204/0203 , C12Y207/11022 , A61K2300/00
摘要: Provided herein are methods for increasing telomere length comprising contacting a cell with an agent that activates the ataxia telangiectasia mutated (ATM) kinase pathway or a cyclin dependent kinase pathway, thereby elongating telomeres in the cell. Also provided is a method for treating disorders such as cancer and telomere syndromes.
-
-
-
-